T Cell Therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
38
NCT06704152
BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS
Phase: Phase 1/2
Role: Lead Sponsor
Start: Feb 4, 2025
Completion: Mar 31, 2029
Loading map...